Angaben zum Autor und/oder zum Fachberater finden Sie am Ende des Beitrags.

Chemotherapy

An international forum on all aspects of antimicrobial and antitumor chemotherapy

This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.

 

Editor-in-Chief
Minotti, Rome

Bibliographic Details
Chemotherapy
Journal Abbreviation: Chemotherapy
ISSN: 0009-3157 (Print)
e-ISSN: 1421-9794 (Online)
www.karger.com/CHE

 

Indexing/Abstracting
Listed in bibliographic services, including:

PubMed, MEDLINE, Web of Science, Science Citation Index, Science Citation Index Expanded, Current Contents - Clinical Medicine, Current Contents - Life Sciences, BIOSIS Previews, Google Scholar, Chemical Abstracts Service, CAB Abstracts, Global Health, Scopus, Embase, Pathway Studio, Academic Search, STM Source, Health Research Premium Collection, Medical Database, Health & Medical Collection, ProQuest Central, WorldCat


Journal Contact

Editorial Office:
Karger AG
Editorial Office 'Chemotherapy'
P.O. Box
CH–4009 Basel (Switzerland)
Tel. +41 61 306 13 61
Fax +41 61 306 14 34
E-Mail ocl@karger.com

 

Customer Service:
Karger AG
P.O. Box
CH-4009 Basel (Switzerland)
Fax +41 61 306 12 34
service@karger.com

Themen:

    Aktualisiert am: 20.10.2017 17:07